Detalles de la búsqueda
1.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32877583
2.
Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer.
J Oncol Pharm Pract
; 29(3): 750-754, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35918825
3.
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(9): 1180-1188, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35964621
4.
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(2): 198-211, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33476593
5.
Is Nutritional Screening of Patients with Lung Cancer Optimal? An Expert Opinion Survey of French Physicians and Surgeons.
Nutr Cancer
; 71(6): 971-980, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31070050
6.
Compliance to regional recommendations for molecular analyses and management of advanced lung cancer patients.
Future Oncol
; 15(18): 2139-2149, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31185741
7.
Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study.
BMC Cancer
; 18(1): 1013, 2018 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30348130
8.
A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity.
BMC Infect Dis
; 18(1): 659, 2018 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30547753
9.
High-fidelity simulation self-training enables novice bronchoscopists to acquire basic bronchoscopy skills comparable to their moderately and highly experienced counterparts.
BMC Med Educ
; 18(1): 191, 2018 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30086734
10.
Implementing flexible bronchoscopy in least developed countries according to international guidelines is feasible and sustainable: example from Phnom-Penh, Cambodia.
BMC Pulm Med
; 17(1): 10, 2017 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28073342
11.
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Lancet Oncol
; 17(7): 984-993, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27283860
12.
Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.
Lancet Oncol
; 17(5): 642-50, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27080216
13.
Inequalities in lung cancer: a world of EGFR.
Eur Respir J
; 47(5): 1502-9, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27030679
14.
Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy.
Eur Respir J
; 48(3): 861-72, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27338193
15.
Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial.
J Am Acad Dermatol
; 74(6): 1077-85, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26946985
16.
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Lancet Oncol
; 16(3): 257-65, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25704439
17.
Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.
Eur Respir J
; 46(6): 1773-80, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26493785
18.
No impact of passive smoke on the somatic profile of lung cancers in never-smokers.
Eur Respir J
; 45(5): 1415-25, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25745045
19.
Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504.
Eur Respir J
; 46(5): 1440-50, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26381515
20.
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers.
Eur Respir J
; 45(5): 1403-14, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25657019